Honest, independent supplement evidence — free for everyone.
SupplementScore is a free, public reference that grades dietary supplements against published clinical trials. Every score traces back to peer-reviewed research. No sponsorships, no affiliates, no ads. This page covers who we are, how scoring works, and the policies that keep the calls honest.
Six clinical dimensions — each scored 1–5, with efficacy and safety weighted highest — roll into one 0–100 composite. That score, gated by the citation and safety rules below, sets the tier.
Why we exist
The right supplement can genuinely change someone's life — better sleep, less joint pain, more energy, fewer migraines. The wrong one can drain a wallet, interact with a prescription, or harm an organ. But finding honest information is nearly impossible. The supplement industry generates over $50 billion a year in the US alone, and most of what you read online is written by someone trying to sell you something.
We built SupplementScore to fix that. The long-term goal is to use the best of clinical evidence, and eventually blood work and DNA, to curate precise, personalized supplement guidance for each individual. We don't sell supplements. We don't accept sponsorships. We don't run affiliate links. SupplementScore is, and will remain, free.
The four evidence tiers
Every supplement on the site is placed in one of four tiers. The tier is the headline call: how confident the evidence is, and what kind of risk profile the supplement carries.
| Tier | What it means | What moves a supplement here |
|---|---|---|
| Tier 1 | Proven effective. Backed by multiple large RCTs and meta-analyses with consistent, replicated results across independent research groups. | ≥1 systematic review or meta-analysis showing a meaningful effect, plus ≥1 independently-funded confirmatory RCT. Industry-only evidence cannot drive a Tier 1 call. |
| Tier 2 | Promising. Supported by clinical trials, but limited to specific populations, conditions, or dosages. Real potential — awaiting larger confirmatory studies. | ≥2 RCTs in a defined population with a consistent direction of effect, but small total N or no meta-analysis yet. |
| Tier 3 | Unproven. Limited or conflicting human data. Marketing claims often outrun the research. Many popular supplements live here. | Mechanistic plausibility, animal data, or single small RCTs only. Surfaced so readers can see what the evidence does and doesn't say. |
| Tier 4 | Risky / avoid. Documented safety risks including organ damage, severe drug interactions, or death. Regulatory warnings issued. Do not use. | FDA warning letter or recall, EMA / EFSA negative opinion, multiple peer-reviewed case reports of serious adverse events, or banned status in any major jurisdiction. |
The six sub-scores
Each supplement carries six 1–5 sub-scores. They roll up into the headline 0–100 score shown on the card, with efficacy and safety weighted highest. The sub-scores let you see why a supplement scores the way it does, instead of treating the headline as a black box. The exact formula lives in app.js under calcScore and is open for inspection.
| Field | What 1 means | What 5 means |
|---|---|---|
| Efficacy | Insufficient evidence of benefit | Conclusive — meta-analytic evidence with consistent direction |
| Safety | Documented serious harm at typical doses | Excellent — no adverse signals across large population studies |
| Research depth | Minimal — <3 published trials | Extensive — >20 trials including meta-analyses |
| Onset | 8+ weeks before noticeable effect | Immediate / hours |
| Cost / value | High cost for marginal benefit | Meaningful effect for low cost |
| Drug-interaction risk | Severe interactions documented | None known |
How tiers move
Tier is a function of the composite score and a citation gate. A high score alone is not enough for Tier 1; a low score alone is not enough to demote from Tier 1. A supplement only moves between tiers when both conditions for the new tier are satisfied at the same time:
- Score band. The composite must fall inside the new tier's range (T1 ≥72, T2 60–71, T3 40–59, T4 <40).
- Citation gate (T1 only). At least one pivotal PubMed-indexed study with a public or nonprofit funder.
- Safety floor (T1 + T2 only). No active FDA / EFSA / TGA / Health Canada warning that renders the supplement inappropriate for the general adult population.
- Replication (T1 only). The pivotal effect has been seen in at least two independent samples — not necessarily two trials, but two analyses that don't share a single research group's data.
Safety-driven moves are an exception: if a major regulator issues a contraindication or recall, the supplement moves to T4 within one deploy cycle regardless of efficacy score. In the prior 12 months: 12 net promotions, 4 demotions, and 1 safety-driven move. The full audit trail lives in _archive/score-changes.csv.
Where the evidence comes from
Not all citations are equal. Where multiple sources speak to a single claim, the stronger evidence type carries more weight in the score. The order below is how we resolve disagreements between sources:
- 01Meta-analyses & Cochrane systematic reviewsPooled effect, risk-of-bias graded
- 02Regulator dossiersFDA / EFSA / EMA / NIH ODS / Health Canada
- 03Independently-funded RCTsDirect evidence in humans
- 04Cohort & observational studiesUseful for safety signals
- 05Mechanistic, animal, or anecdotalHypothesis-generating only
The primary sources every score draws from include PubMed, the Cochrane Library, ClinicalTrials.gov, NIH Office of Dietary Supplements, NCCIH, EFSA, EMA HMPC, Health Canada NNHPD, openFDA FAERS, FDA MedWatch, WHO monographs, USDA FoodData Central, DrugBank, the USPSTF, and top-tier journals (NEJM, Lancet, JAMA, BMJ, AJCN, JISSN). Critical-appraisal frameworks include GRADE, Cochrane RoB 2, AMSTAR-2, CONSORT, and PRISMA. The complete registry of 61 sources is in sources/registry.json; browse the bibliography →
What we explicitly do not use as primary sources: manufacturer literature, affiliate-driven supplement review sites, nutritional industry trade publications, celebrity-endorsed product pages, retailer product pages, multilevel-marketing materials, and influencer or podcast claims. They may appear in an article only as evidence of a marketing claim being analysed.
Funding policy
Industry-funded supplement trials report effect sizes ~20–30% larger on average than independently-funded ones, after controlling for design quality. We don't pretend this away.
- Every cited study is tagged with funder, funder type (
public,industry,mixed,nonprofit,none_disclosed), and a competing-interest flag. - When pooled effect sizes come from industry-funded trials, we apply a ~25% downward adjustment in the narrative. The adjustment is documented per supplement.
- A Tier 1 call requires at least one
publicornonprofit-funded confirmatory study. Industry-only evidence cannot promote a supplement to Tier 1. - Citations visually flag industry funding (amber) and competing-interest disclosures (red) so readers can weigh them themselves.
Why 25% and not 0%: industry-funded trials are not worthless. Many are well-designed and add real evidence. We discount rather than discard. The number is a judgment call drawn from meta-research on funding bias; we'll revise as our own tracking accumulates.
Our own COI policy: SupplementScore is operated as a non-profit. We accept no funding from manufacturers, distributors, retailers, or affiliate programs. We do not run advertising. Hosting and tooling are paid from individual reader donations and the operator's personal funds. Editorial staff disclose any holdings (equity, consulting, speakerships) related to the supplement industry within the prior three years; anyone with active industry ties cannot author or second-read entries where the conflict applies.
Review cadence
Different content carries different stakes. We review accordingly:
| Content | Cadence | Triggers |
|---|---|---|
| Tier 4 (risky/avoid) and safety articles | 14 days or on regulator alert | PubMed + openFDA FAERS + FDA MedWatch RSS + EFSA alerts |
| Tier 1 and breakthrough articles | 30 days | PubMed + Cochrane |
| Pediatric supplements | 30 days | PubMed + AAP + NIH ODS pediatric |
| Tier 2 / Tier 3 supplements | 60 days | PubMed + ODS / EMA |
| Evergreen guides and myth-busting | 90 days | PubMed |
If FDA MedWatch or EFSA publishes an alert for a supplement we track, it jumps the queue regardless of its last-reviewed date. Every supplement card and article shows its Last reviewed date so readers can see how fresh the call is.
How interactions are modeled
The interactions system is built on three pieces. Pairs capture explicit positive synergies — vitamin D3 + K2 for bone density, iron + vitamin C for absorption — each with a 1–5 strength rating. Cautions capture explicit negative pair interactions with severity: either caution (additive risk that warrants attention) or avoid (combinations to skip). St. John's Wort + SSRIs is an avoid for serotonin syndrome; ashwagandha + thyroid medication is a caution. Mechanism groups bundle supplements that share a pathway (bleed, serotonin, sedation, stimulant, hepatotoxic, hypoglycemic, hypotensive, thyroid modulator, and others) and auto-flag any two members against each other.
When you build a stack in your profile, the system flags conflicts in three places: a chip on each card, a grouped row inside the card describing the mechanism, and a top-of-plan banner enumerating every conflict. Drug-supplement interactions are a separate parallel system, currently in build-out as Phase 2 of the roadmap.
Roadmap
Four stages toward hyper-personalized supplement recommendations.
Comprehensive database
780+ supplements evaluated across six clinical dimensions, every rating derived from systematic reviews, meta-analyses, and human trials across 61 trusted sources. Continuously updated.
Personalized recommendations
Profile-based engine that generates a custom supplement plan from your age, sex, goals, conditions, and medications — what to take, what to avoid, dosing, timing, and interactions.
Blood work & lab integration
Upload blood panels or urine tests to identify specific deficiencies. Results analysed against optimal ranges to recommend targeted supplements for what your body actually needs.
DNA-based personalization
Incorporate MTHFR, VDR, CYP, and APOE variants to refine recommendations based on how you absorb, metabolise, and respond to specific nutrients.
What we don't claim
Specifically, we do not diagnose conditions or recommend supplements as treatment for a diagnosed condition, provide individualised dosing (the doses shown are population-level ranges from clinical trials), replace pharmacist or physician review of supplement-medication interactions, endorse specific brands, or claim that any supplement prevents, treats, or cures any disease.
Scores reflect group-level clinical data; individual responses vary by genetics, diet, health status, medications, and pre-existing conditions. Supplement quality varies dramatically between brands — we do not test, certify, or endorse specific products. Always consult a qualified healthcare provider before starting, stopping, or changing supplements, especially if you are pregnant, nursing, or on medications. In a medical emergency, contact your local emergency services immediately.
Glossary
Plain-language definitions for the research terms used across the site. If you've ever wondered what "p < 0.05" means or what "GRADE" actually grades, this is for you.
RCTRandomized controlled trial
DBPCDouble-blind, placebo-controlled
CrossoverCrossover trial
CohortCohort study
Case-controlCase-control study
In vitroIn vitro
SRSystematic review
Meta-analysisMeta-analysis
NMANetwork meta-analysis
GRADEGRADE evidence rating
PRISMAPRISMA reporting standard
SMDStandardized mean difference
RRRelative risk
OROdds ratio
HRHazard ratio
CIConfidence interval (95% CI)
p-valuep-value
NNTNumber needed to treat
PMIDPubMed identifier
DOIDigital Object Identifier
PMCPubMed Central
COIConflict of interest
Funder typeFunder type
public (NIH, NHS, etc.), nonprofit (American Heart Association, etc.), industry (a supplement company), mixed, or none_disclosed. Tier 1 calls require at least one public/nonprofit citation.ULTolerable Upper Intake Level
RDARecommended Dietary Allowance
AIAdequate Intake
EAREstimated Average Requirement
CYP450Cytochrome P450
P-gpP-glycoprotein
Half-lifeHalf-life
AUCArea Under the Curve
CmaxCmax
SNPSingle nucleotide polymorphism
MTHFRMTHFR variant
APOE4APOE4 carrier
Tier 1Tier 1 (Strong Evidence)
Tier 2Tier 2 (Promising)
Tier 3Tier 3 (Trending)
Tier 4Tier 4 (Risky / Avoid)
Flag an error
If you spot an inaccurate claim, click the Flag inaccuracy button on the affected article or supplement card. The form asks for three things: the claim you think is wrong, what you think it should say, and a citation URL (PubMed, DOI, regulator dossier, or peer-reviewed paper).
The citation is required up front because it turns reader feedback into a signal we can act on. Every submission with a citation gets triaged. Submissions touching Tier 4 safety or drug interactions are escalated to same-day review — wrong information about high-stakes content is the highest-liability content on the site, and we treat it that way.
Help build the database
SupplementScore is a community effort. Clinicians, researchers, developers, and writers make the data better every day. Corrections, new evidence, or partnership all welcome.
/s/<slug>.html supplement URLs unified under the canonical /supplement.html?slug=… route — internal supplement clicks now skip the redirect hop and render directly into the canonical card. Hero search dropdown layering fixed so results no longer hide behind the filter pills./m/ — five drug pages at first (amlodipine, gabapentin, semaglutide, sertraline, tramadol), now expanded to eleven. Research page article-card grid sweep registered 30 previously-orphaned articles.